4.7 Article

Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition

Journal

RADIOTHERAPY AND ONCOLOGY
Volume 104, Issue 2, Pages 235-242

Publisher

ELSEVIER IRELAND LTD
DOI: 10.1016/j.radonc.2012.05.009

Keywords

Ionizing radiation; Extracellular matrix; beta 1 integrin; FAK; Head and neck cancer

Funding

  1. Bundesministerium fur Bildung und Forschung [03ZIK041]
  2. Deutsche Krebshilfe e.V. [108976]

Ask authors/readers for more resources

Purpose: Integrin-mediated adhesion to extracellular matrix (ECM) contributes to the regulation of the cellular radiation response in various tumor entities. To evaluate whether targeting of beta 1 integrin enhances the radiosensitivity of head and neck SCC cell lines (HNSCC) was assessed using either inhibitory anti-beta 1 integrin antibodies or specific beta 1 integrin small interfering RNA (siRNA). Materials and methods: The HNSCC cell lines FaDu, UTSCC15 and UTSCC14 were used. Upon beta 1 integrin inhibition, colony formation, proliferation, DNA double strand breaks, adhesion, and migration as well as protein expression and phosphorylation of integrin downstream targets like Focal Adhesion Kinase and AKT were determined Results: We found that siRNA- and antibody-mediated targeting of beta 1 integrin result in a dose- and cell line-dependent radiosensitization that was accompanied by a decreased cell proliferation and an increased number of radiogenic DNA double strand breaks. Analysis of signal transduction events revealed a dephosphorylation of focal adhesion proteins, prevention of radiation-induced phosphorylation of pro-survival protein kinases and impaired cell adhesion and migration upon blocking of beta 1 integrins. Conclusions: Our data suggest that beta 1 integrin critically contributes to the cellular radioresistance of HNSCC. Further studies are warranted to evaluate whether targeting beta 1 integrin emerges as novel approach to improve radiotherapy patients' outcome. (c) 2012 Elsevier Ireland Ltd. All rights reserved. Radiotherapy and Oncology 104 (2012) 235-242

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available